Evaluate the Safety and Efficacy of a Topical Serum (AGE Serum) in Improving Visible Signs of Aging

ConditionLaxity; Skin
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age25-50
SponsorGoldman, Butterwick, Fitzpatrick and Groff

About this trial

The primary objective is to evaluate the safety and efficacy of a topical serum (AGE serum) in improving visible signs of aging (e.g., fine lines, wrinkles, sagging, texture, radiance) on the full face and neck.The study will be conducted in non-menopausal female and male subjects who are on glucagon-like peptide-1 (GLP-1) agonist therapy for weight loss.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Presence of mild to moderate signs of facial aging (e.g., fine lines, laxity, dull texture) based on modified Griffith scale.

Adult men and women aged 25-50 years.

Fitzpatrick skin types I-IV.

Current treatment with a stable dose of GLP-1 agonist medication, including Ozempic, Rybelsus, or Wegovy for at least last 6 months.

Disqualifiers

Pregnancy or planned pregnancy during the study or currently breastfeeding.

Current menopausal state.

Any uncontrolled systemic disease.

Current use of other GLP-1 agonist therapy aside from the GLP-1 agonist class of medications (Ozempic, Rybelsus, or Wegovy).

Trial design

Design model

Single group

Treatments tested in this trial

  • AGE Serum

    Other intervention

    AGE serum is a topical that contains a high concentration of 30% Proxylane and a synergistic blend of fruit-derived flavonoids (blueberry, pomegranate) and Cassia alata extract.

Treatment groups

25 Participants
are divided into 1 treatment group
Group A: AGE ProductExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Modified Griffith Scale

Modified Griffiths 10-point scale to be used for investigator grading of cutaneous signs of photoaging on the face. Global Fine Lines. Scale 0 (no fine lines) to 9 (numerous, many fine lines) Overall Hyperpigmentation: Scale 0 (no hyperpigmentation) to 9 (significant hyperpigmentation) Skin Tone Eveness: Scale 0 (very even tone) to 9 (uneven, discolored appearance) Skin Elasticity: Score 0 (skin feels toned and dense) to 9 (skin feels thin and flabby) Skin Firmness: Score 0 (firm, tight feeling) to 9 (loose, lax feeling) Skin Radiance: Score 0 (very radiant, luminous, glowing) to 9 (very dull) Skin Texture: Score 0 (very smooth) to 9 (very rough)

Time frame
Baseline, Week 6 and Week12

Secondary outcomes

1

Physician Global Aesthetic Improvement Scale

Physician Grading: 1. Very Much Improved 2. Much Improved 3. Improved 4. No Change 5. Worse

Time frame
Week 12
2

Subject Global Aesthetic Improvement Scale

Subject Grading: 1. Very Much Improved 2. Much Improved 3. Improved 4. No Change 5. Worse

Time frame
Week 12
3

Subject Self-Assessment Questionnaire

Circle One Skin Feels More Comfortable: Agree Strongly Agree Neither Agree Disagree Disagree Disagree Strongly Skin Appears Younger Looking: Agree Strongly Agree Neither Agree Disagree Disagree Disagree Strongly Skin Appears Healthier: Agree Strongly Agree Neither Agree Disagree Disagree Disagree Strongly Skin Looks Renewed/Revitalized: Agree Strongly Agree Neither Agree Disagree Disagree Disagree Strongly Skin Looks Firmer: Agree Strongly Agree Neither Agree Disagree Disagree Disagree Strongly Skin Feels Elastic : Agree Strongly Agree Neither Agree Disagree Disagree Disagree Strongly Redness Looks Reduced: Agree Strongly Agree Neither Agree Disagree Disagree Disagree Strongly

Time frame
Baseline, Week 6 and Week 12

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: